Exhibit 107
Calculation of Filing Fee Table
Form S-1
(Form Type)
Baudax Bio, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security type |
Security |
Fee |
Amount |
Proposed |
Maximum |
Fee rate |
Amount
of |
|||||||||||||
Fees to Be Paid |
Equity |
Common Stock, par value $0.01 per share |
457(c) |
15,000,000(3) |
$0.43 |
$ | 6,450,000 | 0.00011020 | $ | 710.79 | ||||||||||
Total Offering Amounts | $ | 6,450,000 | $ | 710.79 | ||||||||||||||||
Total Fees Previously Paid | $ | 0 | $ | 0 | ||||||||||||||||
Total Fee Offsets | $ | — | ||||||||||||||||||
Net Fee Due | $ | 710.79 |
(1) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended (the “Securities Act”), based on the average of the high and low sales prices of Baudax Bio, Inc.’s (the “Registrant”) common stock, par value $0.01 per share, as reported on the Nasdaq Capital Market on September 1, 2023. |
(2) | Pursuant to Rule 416(a) under the Securities Act, this registration statement shall also cover an indeterminate number of shares that may be issued and resold resulting from stock splits, stock dividends or similar transactions. |
(3) | Represents shares of common stock that may be issued pursuant to that certain purchase agreement dated as of August 23, 2023 entered into by the Registrant and Alumni Capital LP. |